Antioxidants/pharmacology; Cyclooxygenase 2/metabolism; Gene Expression Regulation, Neoplastic/drug effects; NF-E2-Related Factor 2/metabolism; NF-kappa B/metabolism; Ochratoxins/pharmacology; Oxidative Stress/drug effects; Quercetin/pharmacology; Apoptosis/drug effects; Blotting, Western; Calcium/metabolism; Calcium Channel Blockers/pharmacology; Cell Proliferation/drug effects; Cytokinesis/drug effects; Fluorescent Antibody Technique; Glutathione/metabolism; Hep G2 Cells; Humans; Lipid Peroxidation/drug effects; Micronucleus Tests; Nitrites/metabolism; Oxidation-Reduction; Protein Carbonylation/drug effects; Reactive Oxygen Species/metabolism

2,7-dichlorodihydrofluorescein diacetate; 2,7-dichlorofluorescein; 3,30-di-hexyloxacarbocyanine iodide; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; 4,4-diamidino-2-phenylindole; ANOVA; AO/EB; ARE; Acridine orange/ethidium bromide; Analysis of variance; Antioxidant responsive element; CAT; CBMN; CCCP; COX-2; Carbonyl cyanide m-chlorophenylhydrazone; Catalase; Cyclooxygenase-2; Cytokinesis block micronucleus assay; DAB; DAPI; DCF; DCF-DA; DMEM; DNA damage; DTT; DiOC6; Diaminobenzidine; Dithiothreitol; Dulbecco's modified Eagle's medium; EDTA; Ethylenediamine tetraacetic acid; FBS; Fetal bovine serum; GPx; GSH; GST; Glutathione; Glutathione S transferase; Glutathione peroxidase; IC20; Inducible nitric oxide synthase; Inflammation; Inhibitory concentration 20; Intracellular calcium level; LDH; LPO; LPS; Lactate dehydrogenase; Lipid peroxidation; Lipopolysaccharide; MN; MTT; Micronucleus; NF-κB; NO; Nitric oxide; Nrf-2; Nuclear factor E2 p45-related factor 2; Nuclear factor-kappa B; OPT; OTA; Ochratoxin; Ortho-phthalaldehyde; Oxidative stress; PCC; PMSF; Phenyl methyl sulfonyl fluoride; Protein carbonyl content; Quercetin; ROS; Reactive oxygen species; SOD; Superoxide dismutase; [Ca(2+)](i); iNOS